Temple Bar Investment Trust Plc
Interim Management Statement
For the quarter ended 31 March 2008
Objective
The Company's investment objective is to provide growth in income and capital
to achieve a long term total return greater than the benchmark FTSE All-share
Index, through investment primarily in UK securities. The Company's policy is
to invest in a broad spread of securities with typically the majority of the
portfolio selected from the constituents of the FTSE 100 Index.
Material Events and Transactions
Market conditions in the first quarter of 2008 were very similar to those
prevailing in 2007. Investors continued to worry about the effects of a US and
UK economic downturn whilst continuing to believe that this weakness would have
negligible effects on the strength of developing economies. Resource stocks,
therefore, continued to perform very strongly while consumer related stocks
produced some of the poorest returns.
Temple Bar has maintained its exposure to many of the largest UK listed
stocks. They exhibit balance sheet strength, low ratings, high dividend yields
and reasonably low operational gearing. As yet they have not acquired the
anticipated safe-haven status but with earnings pressure spreading across the
market, these characteristics should become increasingly attractive. Temple
Bar has also continued to purchase those stocks which it is believed most
heavily discount the likelihood of a deep consumer led recession in the UK and
the US. Accordingly, additions have been made to holdings in, amongst others,
JD Wetherspoon, Signet, JJB Sports and Wolseley. These have been funded
through sales of stocks such as Reuters, Qinetiq and Britivic.
A final dividend of 21.07p per share was paid on 31 March 2008 to shareholders
on the register as at 14 March 2008. The total payment for the year ended 31
December 2007 was 30.98p per share.
There were no changes to the Company's share capital over the period.
Top Ten Holdings as at 31 March 2008
£'000 % total assets
Royal Dutch Shell ('B' shares) 41,166 8.61
BP 40,599 8.49
HSBC 39,290 8.22
Vodafone 38,266 8.01
Unilever 29,807 6.24
GlaxoSmithKline 29,395 6.15
HBOS 18,442 3.86
AstraZeneca 15,296 3.20
BT 15,281 3.20
Signet 13,632 ÂÂÂ2.85
281,174 58.83
Financial Performance
Quarter to Year to
31 March 31 December
2008 2007
Total assets less current liabilities £477.9m £557.7m
NAV total return (13.67)% (4.33)%
Dividend yield 4.61% 4.08%
NAV per share (debt at book value) 710.40p 847.33p
NAV per share (debt at market value) 698.28p 835.61p
Price per share 672.00p 731.00p
Discount (debt at market value) 3.8% 12.5%
Discount (debt at book value) 5.4% 13.7%
Benchmark NAV total return
FTSE All-Share Index (9.85)% 5.32%
FTSE 350 Higher Yield index (12.78)% 1.18%
Note: The directors are not aware of any significant events or transactions
which have occurred between the date of the financial information and the date
of publication, which would have a material impact on the financial position of
the Company.
The net asset value is published on a weekly basis and other useful background
information on the Company including downloads of published documentation such
as previous Annual Reports and Monthly Fact Sheets can be found at
www.templebarinvestments.com.
Company Information
Launch date 1926
Year end 31 December
Results
Interim Announcement in July 2008
Final Announcement in February 2009
Dividend payments March, September
Price information Published in the Financial Times under 'Investment
Companies'.
Contact
Martin Slade
Investec Investment Management Limited
2 Gresham Street
London EC2V 7QP
Tel: +44 (0)20 7597 1942
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.